SYPHILIS AND HIV COMORBIDITY: NEGATIVE CLINICAL AND EPIDEMIOLOGIC SYNERGY
https://doi.org/10.22328/2077-9828-2018-10-3-7-16
Abstract
Recently, management of patients co-infected with syphilis and HIV infection is becoming an increasingly important problem. Similarity of circumstances and ways of HIV and syphilis transmission as well as populations at risk of infection suggests that in the coming years the number of cases of co-infection will increase. The .negative synergy. of HIV infection and syphilis has been proven. This means a mutual reinforcement of the negative effect, when each of the diseases in their combination is more unfavorable than the separately existing disease. Syphilis increases the likelihood of HIV acquisition and transmission during unprotected sexual intercourse and contributes to the progression of HIV infection. On the other hand, it is traditionally believed that concomitant HIV infection can significantly change clinical features and course of syphilis and make its diagnosis and treatment more complicated. However, the widespread use of antiretroviral therapy has allowed to significantly reduce this negative effect. The review article is devoted to the problem of the biological and epidemiological .synergy. of these two infections, as well as to the analysis of modern data on the clinical features of syphilis developing against the background of HIV infection.
About the Authors
T. V. Krasnoselskikh
FSBEI HE I.P.Pavlov SPbMU MON Russia
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
Е. B. Manasheva
FSBEI HE I.P.Pavlov SPbMU MON Russia
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
M. А. Gezei
Center for AIDS and Other Infectious Diseases
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
References
1. Belyakov N.A., Rassokhin V.V., Bobreshova A.S. Countermeasures against HIV and increased HIV incidence in Russia. HIV Infection and Immunosuppressive Disorders, 2017, Vol. 9, No. 2, pp. 82–90 (In Russ.).
2. Rassokhin V.V., Belyakov N.A., Rozental V.V., Leonova O.N., Panteleyeva O.V. Secondary and somatic diseases in HIV patients. HIV Infection and Immunosuppressive Disorders, 2014, Vol. 6, No. 1, pp. 7–18 (In Russ.).
3. Oleinik A.F., Fazylova V.Kh. The importance of comorbidity in HIV infection. Infectious Diseases. News, Opinions, Training, 2017, Vol. 18, No. 1, pp. 101–108 (In Russ.).
4. Singer M., Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med. Anthropol. Quart., 2003, Vol. 17, No. 4, pp. 423–441.
5. Situation on HIV-infection in Russia (for 2015) [Electronic resource]. Official website of the Central research Institute of healthcare organization and Informatization. URL: http://mednet.ru/ru/statistika/soczialno-znachimye-zabolevaniya.html (November 28, 2017) (In Russ.).
6. Korobko A.V., Orlova I.A., Smirnova N.V., Dudko V.Yu., Smirnova I.O., Smirnova T.S., Litvinenko I.V., Piriatinskaya A.B., Sevashevich A.V., Gayvoronskaya O.V., Ivanov A.M. Syphilis in HIV patients: the significance of medicosocial factors in the development of the combined infection. HIV Infection and Immunosuppressive Disorders, 2014, Vol. 6, No. 4, pp. 57– 63 (In Russ.).
7. Orlova I.A., Korobko A.V., Smirnova N.V., Dudko V.Yu., Smirnova I.O., Smirnova T.S., Litvinenko I.V., Piriatinskaya A.B., Sevashevich A.V., Gayvoronskaya O.V., Ivanov A.M. Are there special features of clinical manifestations of syphilis in HIV patients? HIV Infection and Immunosuppressive Disorders, 2015, Vol. 7, No. 3, pp. 97–104 (In Russ.).
8. Zetola N.M., Engelman J., Jensen T.P., Klausner J.D. Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clinic Proceedings, 2007, Vol. 82, No. 9, pp. 1091–1102.
9. Chesson H.W., Heffelfinger J.D., Voigt R.F., Collins D. Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex. Transm. Dis., 2005, Vol. 32, No. 5, pp. 265–269.
10. Blocker M.E., Levine W.C., St. Louis M.E. HIV prevalence in patients with syphilis, United States. Sex. Transm. Dis., 2000, Vol. 27, No. 1, pp. 53–59.
11. Krasnoselskikh T.V., Shaboltas A.V., Skochilov R.V., Uraeva G.E. Multidisciplinary model of sexually transmitted infection prevention in the group of injecting drug users. Bulletin of Dermatology and Venereology, 2016, Vol. 3, pp. 62–68 (In Russ.).
12. Adolf R., Bercht F., Aronis M.L., Lunardi L.W., Schechter M., Sprinz E. Prevalence and risk factors associated with syphilis in a cohort of HIV positive individuals in Brazil. AIDS Care, 2012, Vol. 24, No. 2, pp. 252–258.
13. Thurnheer M.C., Weber R., Toutous-Trellu L., Cavassini M., Elzi L., Schmid P., Bernasconi E., Christen A.B., Zwahlen M., Furrer H.; Swiss HIV Cohort Study. Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS, 2010, Vol. 24, No. 12, pp. 1907–1916.
14. HIV infection in the Russian Federation on December 31, 2016. Information [Electronic resource]. Website of the International coalition of readiness for treatment IPTCru (Eastern Europe and Central Asia). URL: http://itpcru.org/ 2017/06/21/spravka-vich-infektsiya-v-rossijskoj-federatsii-na-31-dekabrya-2016 (November 28, 2017) (In Russ.).
15. HIV infection in Saint-Petersburg as 01.07.2017. Information Bulletin of the Saint-Petersburg AIDS Center [Electronic resource]. Official site of Saint-Petersburg Center for AIDS and Other Infectious Diseases. URL: http://www.hiv-spb.ru/inf-bulletin-6–2017.pdf (November 29, 2017) (In Russ.)].
16. Fleming D.T., Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect., 1999, Vol. 75, No. 1, pp. 3–17.
17. Da Ros C.T., Schmitt C.S. Global epidemiology of sexually transmitted diseases. Asian J. Androl., 2008, Vol. 10, No. 1, pp. 110–114.
18. Lafond R.E., Lukehart S.A. Biological basis for syphilis. Clin. Microbiol. Rev., 2006, Vol. 19, No. 1, pp. 29–49.
19. Sellati T.J., Wilkinson D.A., Sheffield J.S., Koup R.A., Radolf J.D., Norgard M.V. Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J. Infect. Dis., 2000, Vol. 181, No. 1, pp. 283–293.
20. Mayer K.H., Venkatesh K.K. Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition. Am. J. Reprod. Immunol., 2011, Vol. 65, No. 3, pp. 308–316.
21. Theus S.A., Harrich D.A., Gaynor R., Radolf J.D., Norgard M.V. Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation. J. Infect. Dis., 1998, Vol. 177, No. 4, pp. 941–950.
22. Buchacz K., Patel P., Taylor M., Kerndt P.R., Byers R.H., Holmberg S.D., Klausner J.D. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS, 2004, Vol. 18, No. 15, pp. 2075–2079.
23. Kofoed K., Gerstoft J., Mathiesen L.R., Benfield T. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex. Transm. Dis., 2006, Vol. 33, No. 3, pp. 143–148.
24. Palacios R., Jimenez-Onate F., Aguilar M., Galindo M.J., Rivas P., Ocampo A., Berenguer J., Arranz J.A., Rios M.J., Knobel H., Moreno F., Ena J., Santos J. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J. Acquir. Immune Defic. Syndr., 2007, Vol. 44, No. 3, pp. 356–359.
25. Rekart M.L., Ndifon W., Brunham R.C., Dushoff J., Park S.W., Rawat S., Cameron C.E. A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum? Sex. Transm. Infect., 2017, Vol. 93, No. 5, pp. 374–378.
26. Azzam R., Lal L., Goh S.L., Kedzierska K., Jaworowski A., Naim E., Cherry C.L., Wesselingh S.L., Mills J., Crowe S.M. Adverse effects of antiretroviral drugs on HIV-1 infected and uninfected human monocyte-derived macrophages. J. Acquir. Immune Defic. Syndr., 2006, Vol. 42, No. 1, pp. 19–28.
27. Johns D.R., Tierney M., Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N. Engl. J. Med., 1987, Vol. 316, No. 25, pp. 1569–1572.
28. Berry C.D., Hooton T.M., Collier A.C., Lukehart S.A. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N. Engl. J. Med., 1987, Vol. 316, No. 25, pp. 1587–1589.
29. Katz D.A., Berger J.R., Duncan R.C. Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Archives of Neurology, 1993, Vol. 50, No. 3, pp. 243–249.
30. Gourevitch M.N., Selwyn P.A., Davenny K., Buono D., Schoenbaum E.E., Klein R.S., Friedland G.H. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Annals of Internal Medicine, 1993, Vol. 118, No. 5, pp. 350–355.
31. Hutchinson C.M., Hook E.W., 3rd, Shepherd M., Verley J., Rompalo A.M. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Annals of Internal Medicine, 1994, Vol. 121, No. 1, pp. 94–100.
32. Flores J.L. Syphilis. A tale of twisted treponemes. West. J. Med., 1995, Vol. 163, No. 6, pp. 552–559.
33. Rompalo A.M., Joesoef M.R., O’Donnell J.A., Augenbraun M., Brady W., Radolf J.D., Johnson R., Rolfs R.T.; Syphilis and HIV Study Group. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex. Transm. Dis., 2001, Vol. 28, No. 3, pp. 158–165.
34. Ghanem K.G., Moore R.D., Rompalo A.M., Erbelding E.J., Zenilman J.M., Gebo K.A. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS, 2008, Vol. 22, No. 10, pp. 1145–1151.
35. Schofer H., Imhof M., Thoma-Greber E., Brockmeyer N.H., Hartmann M., Gerken G., Pees H.W., Rasokat H., Hartmann H., Sadri I., Emminger C., Stellbrink H.J., Baumgarten R., Plettenberg A. Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourinary Medicine, 1996, Vol. 72, No. 3, pp. 176–181.
36. Chan D.J. Syphilis and HIV: when is lumbar puncture indicated? Current HIV Research, 2005, Vol. 3, No. 1, pp. 95–98.
37. Karumudi U.R., Augenbraun M. Syphilis and HIV: a dangerous duo. Expert Review of Anti-Infective Therapy, 2005, Vol. 3, No. 5, pp. 825–831.
38. Rolfs R.T., Joesoef M.R., Hendershot E.F., Rompalo A.M., Augenbraun M.H., Chiu M., Bolan G., Johnson S.C., French P., Steen E., Radolf J.D., Larsen S. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N. Engl. J. Med., 1997, Vol. 337, No. 5, pp. 307–314.
39. Ivars Lleo M., Clavo Escribano P., Menendez Prieto B. Atypical Cutaneous Manifestations in Syphilis. Actas Dermo-sifiliograficas, 2016, Vol. 107, No. 4, pp. 275–283 (In Spanish).
40. Romero-Jimenez M.J., Suarez L.I., Fajardo P.J., Baron F.B. Malignant syphilis in patient with human immunodeficiency virus (HIV): case report and literature review. Anales de Medicina Interna, 2003, Vol. 20, No. 7, pp. 373–376 (In Spanish).
41. Sands M., Markus A. Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review. Clin. Infect. Dis., 1995, Vol. 20, No. 92, pp. 387–390.
42. Rosenheim M., Brucker G., Leibowitch M., Niel G., Bournerias I., Duflo B., Gentilini M. Malignant syphilis in a patient with anti-HIV antibodies. La Presse Medicale, 1987, Vol. 16, No. 16, pp. 777 (In French).
43. Tucker J.D., Shah S., Jarell A.D., Tsai K.Y., Zembowicz A., Kroshinsky D. Lues maligna in early HIV infection case report and review of the literature. Sex. Transm. Dis., 2009, Vol. 36, No. 8, pp. 512–514.
44. Bahmer F.A., Anton-Lamprecht L. Ultrastructural features of malignant syphilis and demonstration of Treponema pallidum. Intern. J. Dermatol., 1983, Vol. 22, No. 3, pp. 165–170.
45. Barros D’Elia Zanella L.G.F.A., Facchini Lellis R., Khoury Z., Keiko Matsuka Oyafuso L., Figueiredo-Mello C. Rupioid lesions, PLEVA and superposition phenomenon in malignant syphilis: two case reports in HIV-infected patients. J. Eur. Acad. Dermatol. Venereol., 2017, August 29. DOI: 10.1111/jdv.14563[Epub ahead of print].
46. Braue J., Hagele T., Yacoub A.T., Mannivanan S., Sokol L., Glass F., Greene J.N. A case of rupioid syphilis masquerading as aggressive cutaneous lymphoma. Mediterr. J. Hematol. Infect. Dis., 2015, Vol. 7, No. 1, pp. e2015026.
47. Yamashita M., Fujii Y., Ozaki K., Urano Y., Iwasa M., Nakamura S., Fujii S., Abe M., Sato Y., Yoshino T. Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma. Diagn. Pathol., 2015, Vol. 10, pp. 185.
48. Mikheev G.N., Krasnoselskikh Т.V., Sokolovskiy E.V., Iastrebov V.V., Grigorian А.E. Papulonodular syphilis: a case of occurrence at the beginning of the secondary stage and literature review. Modern Problems of Dermatovenerology, Immunology and Medical Cosmetology, 2011, Vol. 9, No. 19, pp. 62–68 (In Russ.).
49. Shulkin D., Tripoli L., Abell E. Lues maligna in a patient with human immunodeficiency virus infection. Am. J. Med., 1988, Vol. 85, No. 3, pp. 425–427.
50. Bari M.M., Shulkin D.J., Abell E. Ulcerative syphilis in acquired immunodeficiency syndrome: A case of precocious tertiary syphilis in a patient infected with human immunodeficiency virus. J. Am. Acad. Dermatol., 1989, Vol. 21, No. 6, pp. 1310–1312.
51. Fonseca E., Garcia-Silva J., del Pozo J., Yebra M.T., Cuevas J., Contreras F. Syphilis in an HIV infected patient misdiagnosed as leprosy. J. Cutan. Pathol., 1999, Vol. 26, No. 1, pp. 51–54.
52. Lynn W., Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect. Dis., 2004, Vol. 4, No. 7, pp. 456–466.
53. Dumaresq J., Langevin S., Gagnon S., Serhir B., Deligne B., Tremblay C., Tsang R.S., Fortin C., Coutlee F., Roger M. Clinical prediction and diagnosis of neurosyphilis in HIV-infected patients with early syphilis. J. Clin. Microbiol., 2013, Vol. 51, No. 12, pp. 4060–066.
54. Taylor M.M., Aynalem G., Olea L.M., He P., Smith L.V., Kerndt P.R. A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001–2004. Sex. Transm. Dis., 2008, Vol. 35, No. 5, pp. 430–434.
55. Mishra S., Walmsley S.L., Loutfy M.R., Kaul R., Logue K.J., Gold W.L. Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada. AIDS Patient Care and STDs, 2008, Vol. 22, No. 3, pp. 213–219.
56. Thami G.P., Kaur S., Gupta R., Kanwar A.J., Sood S. Syphilitic panuveitis and asymptomatic neurosyphilis: a marker of HIV infection. Int. J. STD AIDS, 2001, Vol. 12, No. 11, pp. 754–756.
57. McLeish W.M., Pulido J.S., Holland S., Culbertson W.W., Winward K. The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology, 1990, Vol. 97, No. 2, pp. 196–203.
58. Balba G.P., Kumar P.N., James A.N., Malani A., Palestine A.G., Welch J.N., Timpone J.G. Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am. J. Med., 2006, Vol. 119, No. 5, pp. 448.e21–448.e25.
59. Parc C.E., Chahed S., Patel S.V., Salmon-Ceron D. Manifestations and treatment of ocular syphilis during an epidemic in France. Sex. Transm. Dis., 2007, Vol. 34, No. 8, pp. 553–556.
60. Maharajan M., Kumaar G.S. Cardiovascular syphilis in HIV infection: a case-control study at the Institute of Sexually Transmitted Diseases, Chennai, India. Sex. Transm. Infect., 2005, Vol. 81, No. 4, pp. 361.
Review
For citations:
Krasnoselskikh T.V., Manasheva Е.B., Gezei M.А. SYPHILIS AND HIV COMORBIDITY: NEGATIVE CLINICAL AND EPIDEMIOLOGIC SYNERGY. HIV Infection and Immunosuppressive Disorders. 2018;10(3):7-16. (In Russ.) https://doi.org/10.22328/2077-9828-2018-10-3-7-16
Views:
17632
.png)
Email this article 